次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

生物製剤:技術および世界市場2025年予測

Biologic Therapeutic Drugs: Technologies and Global Markets

出版元:BCC ResearchLinkIcon出版元について
発行年:2021年3月
定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文138ページになります。
商品コード:BCC228

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
生物製剤の世界市場規模は2020年の2855億ドルから、2025年には4218億ドルへと増加が予測されます。
当レポートでは、生物製剤の市場/技術的背景、COVID-19の影響、市場ダイナミクス、各種セグメント別市場分析(製品セグメント別、国地域別)、競合状況、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
◆イントロダクション
・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術背景
・バイオ医薬品産業の構造
・バイオテクノロジーの起源
・大規模な製薬会社の関与
・生物製剤の概要
・生物製剤の製造
・バイオ医薬品製造プロセス
・生物製剤に関するFDA規制

◆COVID-19の影響
・短期的影響
・長期的影響
・COVID-19の進行
・COVID-19に関する政府支出
・COVID-19の社会的影響
・保険会社への影響
・医療技術評価への影響

◆市場ダイナミクス
・ドライバー
・障壁
・機会

◆生物製剤市場、製品セグメント別
・治療用タンパク質
・ワクチン
・その他
※市場予測データ-2025年掲載
※国地域別のデータ-2025年掲載

◆生物製剤市場、地域別
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ

◆競合状況
・ファイブフォース分析

◆主要企業プロフィール
・AMGEN INC.
・BAXTER
・CHINA BIOLOGIC PRODUCTS INC.
・CSL LTD.
・DENDREON PHARMACEUTICALS LLC
・ELI LILLY AND CO.
・F. HOFFMANN-LA ROCHE LTD.
・GLAXOSMITHKLINE PLC
・GLYCOTOPE GMBH
・GRIFOLS S.A.
・JSC PHARMSTANDARD
・KEDRION S.P.A.
・NOVARTIS AG
・OCTAPHARMA AG
・RELIANCE LIFE SCIENCES
・SANOFI
・TEVA PHARMACEUTICAL INDUSTRIES LTD.

(全138頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Biologic Therapeutic Drugs: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction

Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Biopharmaceutical Industry Structure
Origins of Biotechnology
Involvement of Large Pharmaceutical Companies
Overview of Biologics
Biologics Manufacturing
Biopharmaceutical Manufacturing Process

  • The Preparation Process
  • Expression Systems for Therapeutic Protein Production
  • E. coli Advantages for Microbial Production
  • Mammalian Cell Therapeutic Protein Production

FDA Regulation of Biologics

Chapter 4 Impact of COVID-19 Pandemic

Introduction
Short-Term Impact
Long-Term Impact

  • Delayed Approvals for Non-COVID-Related Pharmaceutical Products
  • Self-Sufficiency in Pharma Industry

Progression of COVID-19
Government Expenditures on COVID-19
Social Impact of COVID-19
Impact on Insurance Providers
Impact on Health Technology Assessment

  • Changes in Consumption Trends in Health-Related Products

Chapter 5 Market Dynamics

Market Drivers

  • Overview
  • Rising Prevalence of Chronic Diseases
  • Advancement in Biologics
  • Growing Geriatric Population

Market Restraints

  • Emergence of Biosimilars

Market Opportunities

  • Opportunities in Emerging Nations

Chapter 6 Market Breakdown by Product Segment

Global Market for Biologic Therapeutic Drugs by Product Segment

  • Therapeutic Proteins
  • Vaccines
  • Others

Chapter 7 Market Breakdown by Region

Global Market for Biologic Therapeutic Drugs by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 8 Competitive Landscape

Porter's Five Forces Analysis

  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Threat of Substitutes
  • Competitive Rivalry/Degree of Competition

Chapter 9 Company Profiles

AMGEN INC.
BAXTER
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
DENDREON PHARMACEUTICALS LLC
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE PLC
GLYCOTOPE GMBH
GRIFOLS S.A.
JSC PHARMSTANDARD
KEDRION S.P.A.
NOVARTIS AG
OCTAPHARMA AG
RELIANCE LIFE SCIENCES
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.

List of Tables

Summary Table : Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 1 : Biologic Orphan Drugs, by Trade Name and Indication
Table 2 : Expenditures on COVID-19 Crisis, by Selected Country
Table 3 : Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 4 : Number and Distribution of Persons Aged 60 and Over, by Region, 2017 and 2050
Table 5 : Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 6 : Global Market for Biologic Therapeutic Proteins, by Region, Through 2025
Table 7 : Global Market for Biologics Therapeutic Vaccines, by Region, Through 2025
Table 8 : Global Market for Other Biologic Therapeutic Drug Products, by Region, Through 2025
Table 9 : Global Market for Biologic Therapeutic Drugs, by Region, Through 2025
Table 10 : North American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 11 : North American Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 12 : European Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 13 : European Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 14 : Asia-Pacific Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 15 : Asia-Pacific Market for Biologic Therapeutic Drugs, by Country, Through 2025
Table 16 : Japanese Market Statistics
Table 17 : Latin American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 18 : Middle Eastern and African Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Table 19 : Porter's Five Forces Analysis
Table 20 : Amgen Inc.: Product Portfolio
Table 21 : Baxter: Product Portfolio
Table 22 : Baxter: Recent Developments, 2021
Table 23 : China Biologic Products Holdings Inc.: Product Portfolio
Table 24 : China Biologic Products Holdings Inc.: Pipeline Plasma Products
Table 25 : China Biologic Products Holdings Inc.: Recent Developments, 2017
Table 26 : CSL Ltd.: Products Portfolio
Table 27 : CSL Ltd.: Recent Developments, 2021
Table 28 : Dendreon Pharmaceuticals LLC: Product Portfolio
Table 29 : Eli Lilly and Co.: Product Portfolio
Table 30 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 31 : F. Hoffmann-La Roche Ltd.: Revenues, by Business Segment, 2016-2018
Table 32 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 33 : GlaxoSmithKline Plc: Financials, 2017-2019
Table 34 : GlaxoSmithKline Plc: Products and Services
Table 35 : Glycotope GmbH: Product Portfolio
Table 36 : Grifols S.A.: Product Portfolio
Table 37 : Grifols S.A.: Recent Developments, 2020
Table 38 : JSC Pharmstandard: Product Portfolio
Table 39 : Kedrion S.p.A.: Products and Services
Table 40 : Kedrion S.p.A.: Developments and Strategies
Table 41 : Novartis AG: Product Portfolio
Table 42 : Octapharma AG: Products and Services
Table 43 : Octapharma AG: Recent Developments, 2020
Table 44 : Reliance Life Sciences: Product Portfolio
Table 45 : Sanofi: Products and Services
Table 46 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 47 : Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019

List of Figures

Summary Figure : Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 1 : Impact of COVID-19 on the Pharmaceutical Industry
Figure 2 : Comparison of GDP Growth, by Country, 2019 and 2020
Figure 3 : Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 4 : Global Market for Biologic Therapeutic Proteins, 2018-2025
Figure 5 : Global Market for Biologic Therapeutic Proteins, by Region, 2018-2025
Figure 6 : Global Market for Biologics Therapeutic Vaccines, 2018-2025
Figure 7 : Global Market for Biologics Therapeutic Vaccines, by Region, 2018-2025
Figure 8 : Global Market for Other Biologic Therapeutic Drug Products, 2018-2025
Figure 9 : Global Market for Other Biologic Therapeutic Drug Products, by Region, 2018-2025
Figure 10 : Global Market for Biologic Therapeutic Drugs, by Region, 2018-2025
Figure 11 : Global Market Shares of Biologic Therapeutic Drugs, by Region, 2019
Figure 12 : North American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 13 : North American Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 14 : U.S. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 15 : Canadian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 16 : European Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 17 : European Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 18 : German Market for Biologic Therapeutic Drugs, 2018-2025
Figure 19 : U.K. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 20 : French Market for Biologic Therapeutic Drugs, 2018-2025
Figure 21 : Italian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 22 : Spanish Market for Biologic Therapeutic Drugs, 2018-2025
Figure 23 : Rest of European Market for Biologic Therapeutic Drugs, 2018-2025
Figure 24 : Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 25 : Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 26 : Chinese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 27 : Japanese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 28 : Indian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 29 : Rest of Asia-Pacific Market for Biologic Therapeutic Drugs, 2018-2025
Figure 30 : Latin American Market for Biologic Therapeutic Drugs, 2018-2025
Figure 31 : Latin American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 32 : Middle Eastern and African Market for Biologic Therapeutic Drugs, 2018-2025
Figure 33 : Middle Eastern and African Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 34 : Amgen Inc.: Annual Revenue, 2015-2019
Figure 35 : Amgen Inc.: Revenue Share, by Country, 2019
Figure 36 : Baxter: Annual Revenue, 2015-2019
Figure 37 : Baxter: Revenue Share, by Business Unit, 2019
Figure 38 : Baxter: Revenue Share, by Region, 2019
Figure 39 : China Biologic Products Holdings Inc.: Financials, 2015-2019
Figure 40 : China Biologic Products Holdings Inc.: Revenue Share, by Segment, 2019
Figure 41 : CSL Ltd.: Financials, 2015-2019
Figure 42 : CSL Ltd.: Revenue Share, by Segment, 2019
Figure 43 : CSL Ltd.: Revenue Share, by Country/Region, 2019
Figure 44 : Eli Lilly and Co.: Annual Revenue, 2017-2019
Figure 45 : Eli Lilly and Co.: Revenue Share, by Region, 2019
Figure 46 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
Figure 47 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, 2019
Figure 48 : GlaxoSmithKline Plc: Revenue Share, by Business Segment, 2019
Figure 49 : GlaxoSmithKline Plc: Revenue Share, by Region, 2019
Figure 50 : Grifols S.A.: Financials, 2015-2019
Figure 51 : Grifols S.A.: Revenues Share, by Segment, 2019
Figure 52 : Grifols S.A.: Revenue Share, by Region, 2019
Figure 53 : Kedrion S.p.A.: Financials, 2015-2019
Figure 54 : Kedrion S.p.A.: Revenue Share, by Segment, 2019
Figure 55 : Kedrion S.p.A.: Revenue Share, by Region, 2019
Figure 56 : Novartis AG.: Annual Revenue, 2015-2019
Figure 57 : Novartis AG: Revenue Share, by Region, 2019
Figure 58 : Novartis AG: Revenue Share, by Business Segment, 2019
Figure 59 : Octapharma AG: Financials, 2015-2019
Figure 60 : Octapharma AG: Revenue, by Operating Income, 2015-2019
Figure 61 : Sanofi: Annual Revenue, 2017-2019
Figure 62 : Sanofi: Revenue Share, by Business Segment, 2019
Figure 63 : Sanofi: Revenue Share, by Region, 2019
Figure 64 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019



掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。